Back to search results

Cervical Cancer Screening in Low-Resource Communities

This study, called "Prevención en Sus Manos," is looking at a new way to help more women get screened for cervical cancer. Cervical cancer can be prevented by checking for the human papillomavirus (HPV), which causes most cases. The study is testing a program called PRECEDE-PROCEED, where community health workers (CHWSS) help women do HPV self-sampling. This study wants to see if this method is practical and acceptable for women in the Rio Grande Valley (RGV) and other areas in Texas where resources are limited. We are looking for about 920 women, aged 25 and older, who live in these communities and have not had a hysterectomy (surgery to remove the uterus and cervix). The main goal is to track any side effects that might happen during the study, which will last about one year.

Study design
This is an interventional study, meaning participants will receive a specific intervention (CHW-delivered self-sampling for HPV testing). The study plans to enroll 920 participants.
What's involved
You would need to provide signed consent and be willing to follow all study procedures. The study will assess your participation in HPV screening and how you feel about the process.
Compensation
Not stated in the trial record.
Follow-up
Adverse events will be measured through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06109870

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

Recruiting
NAAges 18+InterventionalTreatment
M.D. Anderson Cancer Center
~920 participants
Updated 2026-08-14 on ClinicalTrials.gov
What's tested:PRECEDE-PROCEED

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Measured over through study completion; an average 1 year.

Conditions

HPV

Explore related trials

Cervical Carcinoma

Where it's being run

2 sites across 1 states
Texas2

Study leadership

  • Jane Montealegre, M D · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Jane Montealegre, M D
[email protected]
(281) 814-7118
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Provision of signed and dated informed consent form
Currently resident in RGV or other low-resource community in Texas
Stated willingness to comply with all study procedures
Females; Age ≥25 years
Have no history of hysterectomy with removal of the cervix
Have no history of cervical cancer or high-grade dysplasia
Have not had a Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years.

Exclusion

Unable to communicate in English or Spanish
Lack valid telephone contact information
Report being currently pregnant.

What this trial measures

  • Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0through study completion; an average 1 year.